Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | SYK | P43405 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | USP1 | O94782 | 1/20 | 0.36 |
| ▸ | WDR48 | Q8TAF3 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3684203 | 0.83 | LPAR1 (0.48) | LPAR1ELANEKDM4EMEN1CYP3A4 | |
| SCHEMBL24133302 | 0.80 | LMNA (0.40) | KDM4EL3MBTL1MEN1CYP3A4CYP2C9 | |
| SCHEMBL22320291 | 0.79 | L3MBTL1 (0.47) | PTGDR2NPC1SYKKDM4EL3MBTL1 | |
| SCHEMBL22320330 | 0.76 | L3MBTL1 (0.32) | NPC1LPAR1USP1WDR48L3MBTL1 | |
| SCHEMBL30423230 | 0.76 | L3MBTL1 (0.32) | NPC1LPAR1USP1WDR48L3MBTL1 | |
| SCHEMBL1446331 | 0.74 | KMT2A (0.51) | L3MBTL1MEN1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL22320292 | 0.74 | PTGDR2 (0.35) | PTGDR2NPC1SYKKDM4EL3MBTL1 | |
| SCHEMBL28926527 | 0.72 | KMT2A (0.36) | NPC1KDM4EL3MBTL1MEN1CYP1A2 | |
| SCHEMBL30930957 | 0.72 | L3MBTL1 (0.42) | PTGDR2NPC1L3MBTL1MEN1CYP1A2 | |
| SCHEMBL14460781 | 0.71 | PTGDR2 (0.40) | PTGDR2NPC1SYKKDM4EL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3924395-A1 | B!S(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2021-12-22 | — | — | EP | disclosed |
| US-11203654-B2 | Bis(aryl phenolate) lewis base catalysts and methods thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-12-21 | — | — | US | disclosed |
| US-11203654-B2 | Bis(aryl phenolate) lewis base catalysts and methods thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-12-21 | — | — | US | disclosed |
| WO-2020167824-A1 | B!S(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-08-20 | — | — | WO | disclosed |
| WO-2020167824-A1 | B!S(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-08-20 | — | — | WO | disclosed |
| US-20200254431-A1 | BIS(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-08-13 | — | — | US | disclosed |
| US-20200254431-A1 | BIS(ARYL PHENOLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11203654-B2 | Bis(aryl phenolate) lewis base catalysts and methods thereof | PHKB, TYR, ELL | PTGDR2 1682/4885NPC1 4864/4885LPAR1 742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.